Immunogenicity and Safety of Fluzone® Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route)
Clinical trial NCT03546192 · COMPLETED
Trial details
- NCT number
- NCT03546192
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-17
- Primary completion
- 2015-07-17
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.